Cannabis, Cancer Immunotherapy & Immunobiology Research Center
Cancer Immunotherapy & Immunobiology Research Center specialises in the herbs/cannabis active compound research projects, opening novel perspectives for clinical applications and development of successful therapeutic agents. The unique sinergy of Prof. Reuven Or’s clinical expertise and scientific excellence of Dr. Almogi-Hazan creates substantial added value for the preclinical research, provided as a service to the industry.
Cannabis/Herbs focus
• Discovering impact of endocannabinoid system on immunity
• Exploring the effects of cannabinoids and herbs bioactive compounds on the immune response in different pathologies
• Anti-inflammatory medical cannabis and herbal products research
• Wide spectrum of animal models and assays for preclinical studies
Added Value
• Clinical input of the cannabis therapist
• Deep understanding of the industries’ challenges
• Human samples access under IRB requirements
• Animal facility access under AAALAC, NIH
and Israel MOH accreditation
• Compliance with the regulatory and security
requirements for cannabis/drug research
Pre-clinical research fields
- Cannabis and cannabinoids
- Cancer
- Hematopoietic stem cells
- Mesenchymal stem cells
- Cord blood
- Cell therapy
- Immunotherapy
- Transplantation
- Innovative GVHD therapies
